Právní předpis byl sestaven k datu 17.01.2025.
Zobrazené znění právního předpisu je účinné od 17.01.2025.
§1
Xxxxxxx xxxxxx
Xxxx xxxxxxxx xxxxxxx xxxxxx xxxxxxxxxx xxxxxxxxxxxxxxx látek, xxxxx xx xxxxxx v příloze x xxxxxx xxxxxxxx.
§2
Xxxxxxxx xxxxxxxxxxx xxxxxxxx
Xxxx xxxxxxxx xxxx xxxxxxxx x souladu se xxxxxxxx Xxxxxxxxxx xxxxxxxxxx x Rady (EU) 2015/1535 xx xxx 9. xxxx 2015 x xxxxxxx xxx xxxxxxxxxxx xxxxxxxxx v xxxxxxx norem x xxxxxxxxxxx xxxxxxxx a xxxxxxxx xxx služby xxxxxxxxxx xxxxxxxxxxx.
§3
Účinnost
Toto nařízení xxxxxx xxxxxxxxx xxxx xxxxxxxxxxxx xx dni xxxx xxxxxxxxx.
&xxxx;
Xxxxxxxx xxxxx:
xxxx. XxXx. Xxxxx, Ph.D., XX.X., x. r.
Místopředseda vlády x xxxxxxx zdravotnictví:
prof. XXXx. Válek, CSc., XXX, XXXX, v. x.
Xxxxxxx
Xxxxxx zařazených xxxxxxxxxxxxxxx xxxxx
Xxxxxxxxxxx xxxxxxxxxx xxxxx (XXX) x českém xxxxxx |
Xxxxx xxxxxxxxxxx nechráněný xxxxx nebo xxxxxx xxxxx |
Xxxxxxxx název podle XXXXX |
Xxxxx |
Xxxxxxxx |
Xxxxxxxxxxxxxxxxxxxx |
XXXX |
6,6,9-xxxxxxxxx-3-xxxxxx-6x,7,8,9,10,10x-xxxxxxxxx benzo[c]chromen-1-ol |
||
Hexahydrokanabihexol |
HHCH; XXX-X6 |
6,6,9-xxxxxxxxx-3-xxxxx-6x,7,8,9,10,10x-xxxxxxxxx xxxxx[x]xxxxxxx-1-xx |
||
Xxxxxxxxxxxxxxxxxx |
XXX |
(6xX,10xX)-6,6,9-xxxxxxxxx-3-xxxxxx-6x,7,8,9,10,10x-xxxxxxxxxxxxxx[x]xxxxxxx-1-xx |
X xxxxxxxx xxxxx XXX, xxxxx je xxxxxxxx v xxxxxxxx xxxxxxxxxxx xxxxxx, xxxxxxxxxx xxxxxx, xxxxxx extrakt x xxxxxxxx x xxxxxxxxx x xxxxxxxxxxx xxxxxx v množství xxxxxx xxx 0,3 %. Tato xxxxxxx xx xxxxxxxxxx na xxxxxxxxx. |
|
Xxxxxxxxxxxxxxxxxxxx |
XXX-X8 |
6,6,9-xxxxxxxxx-3-xxxxx-6x,7,8,9,10,10x-xxxxxxxxx xxxxx[x]xxxxxxx-1-xx |
||
Xxxxxxxxxxxxxxxxxx |
XXXX; HHC-C4 |
6,6,9-trimethyl-3-butyl-6a,7,8,9,10,10a-hexahydro xxxxx[x]xxxxxxx-1-xx |
||
Xxxxxxxxxxxxxxxxxxxxx |
XXXX |
(6xX,10xX)-3-xxxxxx-6,6,9-xxxxxxxxx-6x,7,8,10x-xxxxxxxxxxxxxxx[x]xxxxxxx-1-xx |
X xxxxxxxx xxxxx XXXX, xxxxx je xxxxxxxx x rostlině xxxxxxxxxxx xxxxxx, xxxxxxxxxx xxxxxx, xxxxxx extrakt x xxxxxxxx a xxxxxxxxx x xxxxxxxxxxx xxxxxx x xxxxxxxx xxxxxx xxx 0,3 %. Tato xxxxxxx xx nevztahuje xx xxxxxxxxx. |
|
Xxxxxxxxxxxxxxxxxxxxx |
XXXX; XXX-X6 |
(6xX,10xX)-3-xxxxx-6,6,9-xxxxxxxxx-6x,7,8,10x-xxxxxxxxxxxxxxx[x]xxxxxxx-1-xx |
Xxxxxx xxxxx-8 xxxxxxx. |
|
Xxxxxxxxxxxxxxxxxxxxx |
XXX-X8 |
(6xX,10xX)-3-xxxxx-6,6,9-xxxxxxxxx-6x,7,8,10x-xxxxxxxxxxxxxxx[x]xxxxxxx-1-xx |
Xxxxxx xxxxx-8 izomeru. |
|
Tetrahydrokanabutol |
THCB; XXX-X4 |
(6xX,10xX)-3-xxxxx-6,6,9-xxxxxxxxx-6x,7,8,10x-xxxxxxxxxxxxxxx[x]xxxxxxx-1-xx |
Xxxxxx delta-8 xxxxxxx. |
|
5-Methylthiopropamin |
1-(5-methylthiofen-2-yl)propan-2-amin |
|||
BOH-PHP |
1-fenyl-2-(pyrrolidin-1-yl)hexan-1-ol |
|||
M-ALPHA-HCMA |
3-(2H-1,3-benzodioxol-5-yl)-2-hydroxy-N,2-dimethyl-3-(methylamino)propanamid |
|||
Mefedren |
N-methyl-1-(5-methyl-2-thienyl)propan-2-amin |
|||
2-Fluor-deschlor-N-ethylketamin |
2-(ethylamino)-2-(2-fluorfenyl)cyklohexanon |
|||
3-Cl-PCP |
1-[1-(3-chlorfenyl)cyklohexyl]piperidin |
|||
3F-PCP |
1-[1-(3-fluorfenyl)cyklohexyl]piperidin |
|||
3-Me-PCP |
1-[1-(3-methylfenyl)cyklohexyl]piperidin |
|||
3-Me-PCPy |
1-[1-(3-methylfenyl)cyklohexyl]pyrrolidin |
|||
Deoxymethoxetamin |
2-(ethylamino)-2-(3-methylfenyl)-cyklohexanon |
|||
Fluorexetamin |
2-(ethylamino)-2-(3-fluorfenyl)cyklohexan-1-on |
|||
Hydroxetamin |
2-(ethylamino)-2-(3-hydroxyfenyl)-cyklohexanon |
|||
Methoxisopropamin |
2-(isopropylamino)-2-(3-methoxyfenyl)cyklohexanon |
|||
4'-Chlordeschloralprazolam |
6-(4-chlorfenyl)-1-methyl-4H-[1,2,4]triazolo[4,3-a][1,4]benzodiazepin |
|||
Bretazenil |
1,1-dimethylethyl 8-xxxx-11,12,13,13x-xxxxxxxxxx-9-xxx-9X-xxxxxxx[1,5-x]xxxxxxx[2,1-x][1,4]xxxxxxxxxxxxx-1-xxxxxxxxxx |
|||
Xxxxxxxxxxxxxxxxx |
7-xxxx-5-xxxxx-1,3-xxxxxxx-2X-1,4-xxxxxxxxxxxxx-2-xx |
|||
Xxxxxxxxxxxxxxxxxx |
2-xxxxx-9-xxxxxx-4-xxxxx-6X-xxxxxx[3,2-x][1,2,4]xxxxxxx[4,3-x][1,4]xxxxxxxx |
|||
Xxxxxxxxxxxxx |
2-xxxx-4-(2-xxxxxxxxxx)-9-xxxxxx-6X-xxxxxx[3,2-x][1,2,4]xxxxxxxx [4,3-x][1,4]xxxxxxxx |
|||
Xxxxxxxxxxx |
2-xxxxx-4-(2-xxxxxxxxxx)-9-xxxxxx-6X-xxxxxx[3,2-x][1,2,4]xxxxxxxx[4,3-x][1,4]xxxxxxxx |
|||
6-XX-XXXXX |
2-xxxx-4,5-xxxxxxxxxxxxxxxxxxxxx |
|||
X-xxxxxxxxxxxx-3,4-XXX |
1-[2-(3,4-xxxxxxxxxxxxxx)-1-xxxxxxxxxxx]-xxxxxxxxxx |
|||
XXXX |
X-xxxxx-1-xxxxxxxxxxx-2-xxxx |
|||
2-(4-Xxxxxxxxxxxxxxx-1-xx)-1-xxxxx propan-1-on |
2-(4-methylpiperazin-1-yl)-1-fenylpropan-1-on |
|||
2-MEB |
2-(ethylamino)-1-(2-methylfenyl)butan-1-on |
|||
2'-Me-PVP |
1-(2-methylfenyl)-2-(pyrrolidin-1-yl)pentan-1-on |
|||
2-Methyl-α-PHiP |
4-methyl-1-(2-methylfenyl)-2-(pyrrolidin-1-yl) xxxxxx-1-xx |
|||
3,4-Xx-XxxXX |
1-(2,3-xxxxxxx-1X-xxxxx-5-xx)-2-(xxxxxxxxx-1-xx) xxxxxx-1-xx |
|||
3X-XXX |
2-(xxxxxxxxxx)-1-(3-xxxxxxxxxx)xxxxx-1-xx |
|||
3X-X-xxxxxxxxxxxxx |
2-(xxxxxxxxxx)-1-(3-xxxxxxxxxx)xxxxx-1-xx |
|||
3X-α-XXX |
1-(3-xxxxxxxxxx)-2-(xxxxxxxxxx-1-xx)xxxxx-1-xx |
|||
3-Xxxxxxxxxxxxx |
2-xxxxx-1-(3-xxxxxxxxxx)xxxxxx-1-xx |
|||
3'-Xx-XXX |
1-(3-xxxxxxxxxxx)-2-(xxxxxxxxxx-1-xx)xxxxxx-1-xx |
|||
3-Xxxxxx-X-xxxxxx-xxxxxxxx |
2-(xxxxxxxxxxx)-1-(3-xxxxxxxxxxx)-1-xxxxxxxx |
|||
4’-Xxxxxxxxxxxxxx |
2-(xxxxxxxxxxx)-1-(4-xxxxxxxxxxx)-1-xxxxxxx |
|||
4-Xx-3-XXX |
1-(4-xxxxx-3-xxxxxxxxxxx)-2-(xxxxxxxxxxx)xxxxxx-1-xx |
|||
4X-3-xxxxxx-α-XXX |
1-(4-xxxxx-3-xxxxxxxxxxx)-2-xxxxxxxxxx-1-xx-xxxxx-1-xx |
|||
4X-3-xxxxxx-α-XXX |
1-(4-xxxxx-3-xxxxxxxxxxx)-2-(xxxxxxxxxx-1-xx)xxxxxx-1-xx |
|||
XXXXX |
1-(1,3-xxxxxxxxxxx-5-xx)-2-(xxxxxxxxxx-1-xx)xxxxxx-1-xx |
|||
XXXXxX |
1-(1,3-xxxxxxxxxxx-5-xx)-4-xxxxxx-2-xxxxxxxxxx-1-xx-xxxxxx-1-xx |
|||
X,X-xxxxxxxxxxxxxxx |
1-(1,3-xxxxxxxxxxx-5-xx)-2-(xxxxxxxxxxxx)xxxxxx-1-xx |
|||
X-xxxxxxxxxxxx |
1-(2X-1,3-xxxxxxxxxxx-5-xx)-2-(xxxxxxxxxx)xxxxx-1-xx |
|||
X-xxxxxxxxxx xxxxxxx |
1-(1,3-xxxxxxxxxxx-5-xx)-2-(xxxxxxxxxxxxxxx)xxxxx-1-xx |
|||
X-xxxxxxxxxx xxxxxxxx |
1-(1,3-xxxxxxxxxxx-5-xx)-2-(xxxxxxxxxxxxxxx)xxxxxx-1-xx |
|||
X-xxxxxxxxxxxxx |
1-(1,3-xxxxxxxxxxx-5-xx)-2-(xxxxxxxxxx)xxxxxx-1-xx |
|||
X-xxxxxxxxxxxx |
1-(1,3-xxxxxxxxxxx-5-xx)-2-(xxxxxxxxxx)xxxxx-1-xx |
|||
X-xxx-xxxxx-xxxxxxxxx |
2-[(xxxxx-2-xx)xxxxx]-1-xxxxxxxxxxx-1-xx |
|||
α-X2XX |
1,2-xxxxxxx-2-(xxxxxxxxxx-1-xx)xxxxx-1-xx |
|||
α-XXXX |
2-xxxxxxxxxx-1-xxxxx-2-(xxxxxxxxxx-1-xx)xxxxx-1-xx |
|||
3-Xxxxxxxxxxxxxxxx |
2-(3-xxxxxxxxxx)-3-xxxxxxxxxxxxxx |
|||
3-Xxxxxxxxxxxxxxxxxx |
2-(3-xxxxxxxxxxxx)-3-xxxxxxxxxxxxxx |
|||
4Xx-XXX |
5-(4-xxxxxxxxx)-4-xxxxxx-4,5-xxxxxxx-1,3-xxxxxx-2-xxxx |
|||
4Xx-XXX |
5-(4-xxxxxxxxxx)-4-xxxxxx-4,5-xxxxxxx-1,3-xxxxxx-2-xxxx |
|||
4-Xxxxxxxxxxxx |
4-xxxxx-3-(4-xxxxxxxxxx)xxxxxxxx |
|||
Xxxxxxxxxxxxxxxxx |
5-xxxxx-3-(4-xxxxx-2-xxxxxxxxxxx)-2-xxxxxx-4(3X)-xxxxxxxxxxxx |
|||
Xxxxxxxxx |
2-xxxxx-3-xxxxxxxxxxxxxxx-4(3X)-xx |
|||
Xxxxxxxxx |
2-(xxxxxxxxxx)-5-xxxxx-4(5X)-xxxxxxxx |
|||
Xxx-(xxxx-xxxxxx-xxxxxxxxxxxx) |
1-(3-xxxxxxxxxxx)-1-(xxxxxxxxxxx)xxxxxx-2-xx |
|||
Xxx-3-XXX |
1-(3-xxxxxxxxxx)-1-(xxxxxxxxxxx)xxxxxx-2-xx |
|||
Xxx-3-XXX |
1-(xxxxxxxxxxx)-1-(3-xxxxxxxxxxx)xxxxxx-2-xx |
|||
X-xxxxx xxxxxxxx |
X-xxxxx-2-[6-xxxxxx-2-(4-xxxxxxxxxxx)xxxxxxx[1,2-x]xxxxxxx-3-xx]xxxxxxxx |
|||
Xxxxxxxxxxxxxxx |
3-(2-xxxxxxx-4-xxxxxxxxxx)-2-xxxxxxxxxxxxxxxx-4-xx |
|||
Xxxxxxxx |
2-(7-xxxxx-1,8-xxxxxxxxxx-2-xx)-2,3-xxxxxxx-3-(5-xxxxxx-2-xxxxxxxx)-1X-xxxxxxxx-1-xx |
|||
Xxxxxxxxxx |
5-[[(2-xxxxxxxxxxx)xxxxx]xxxxxx]-1-[4-xxxxx-2-(2-xxxxxxxxxxxx)xxxxx]-X,X-xxxxxxxx-1X-1,2,4-xxxxxxx-3-xxxxxxxxxx |
|||
3,4-XXX |
1-(3-xxxxx-4-xxxxxxxxxx)xxxxxxxxx |
|||
4X-XXXX |
1-[(4-xxxxxxxxxx)xxxxxx]-4-xxxxxxxxxxxxxxx |
|||
xXXX |
1-(4-xxxxxxxxx)xxxxxxxxx |
|||
4,4-Xxxxxxxx-1-xxxxx-1-xxxxxxxxxx-1-xx-xxxxxx-3-xx |
4,4-xxxxxxxx-1-xxxxx-1-xxxxxxxxxx-1-xx-xxxxxx-3-xx |
|||
Xxxxxx 2-fenyl-2-(pyrrolidin-1-yl) xxxxxx |
xxxxxx 2-fenyl-2-(pyrrolidin-1-yl)acetát |
|||
3,5-ADB-4en-PFUPPYCA |
N-(1-karbamoyl-2,2-dimethyl-propyl)-5-(4-fluorfenyl)-2-pent-4-enyl-pyrazol-3-karboxamid |
|||
4en-PDMB-4en-PINACA |
pent-4-en-1-yl 3,3-xxxxxxxx-2-(1-(xxxx-4-xx-1-xx)-1X-xxxxxxx-3-xxxxxxxxxxx)-xxxxxxxx |
|||
4X-XXXXXXX |
X-(xxxxxxxxx-1-xx)-1-(4-xxxxxxxxxx)-1X-xxxxxxx-3-xxxxxxxxxx |
|||
5,3-XX-XXXXXXXXXX |
X-(1-xxxxx-3-xxxxxx-1-xxxxxxxx-2-xx)-1-(xxxxxxxxxxxxxxxx)-5-(4-xxxxxxxxxx)-1X-xxxxxxx-3-xxxxxxxxxx |
|||
5,3-XXX-4xx-XXXXXXXX |
X-(1-xxxxxxxxx-2,2-xxxxxxxx-xxxxxx)-5-(4-xxxxxxxxxx)-1-xxxx-4-xxxx-xxxxxxx-3-xxxxxxxxxx |
|||
5X-XXX48 |
X-(1-xxxxxxxxx)-1-(5-xxxxxxxxxx)xxxxxxx-3-xxxxxxxxxx |
|||
5X-XXX-XXXXXXX |
X-[(X)-[1-(5-xxxxxxxxxxx)-2-xxx-xxxxxxx-3-xxxxxx]xxxxx] xxxxxxxx |
|||
5X-XXXX-XXXX |
xxxxx 2-(1-(5-xxxxxxxxxxx)-1X-xxxxx-3-xxxxxxxxxxx)-3,3-xxxxxxxxxxxxxxxx |
|||
5X-XXX-XXXX |
xxxxx 2-[[1-(5-fluorpentyl)indol-3-karbonyl]amino]-3-methyl-butanoát |
|||
ABO-4en-PINACA |
N-(1-amino-1-oxobutan-2-yl)-1-(pent-4-en-1-yl)-1H-indazol-3-karboxamid |
|||
ADB-4en-P-5Br-INACA |
N-(1-amino-3,3-dimethyl-1-oxobutan-2-yl)-5-brom-1-(pent-4-en-1-yl)-1H-indazol-3-karboxamid |
|||
ADB-4en-PINACA |
N-(1-amino-1-oxobutan-2-yl)-1-(pent-4-en-1-yl)-1H-indazol-3-karboxamid |
|||
ADB-5Br-INACA |
N-(1-amino-3,3-dimethyl-1-oxobutan-2-yl)-5-brom-1H-indazol-3-karboxamid |
|||
ADB-B-5Br-INACA |
N-(1-amino-3,3-dimethyl-1-oxobutan-2-yl)-5-brom-1-butyl-1H-indazol-3-karboxamid |
|||
ADB-BUTINACA |
N-(1-amino-3,3-dimethyl-1-oxobutan-2-yl)-1-butyl-1H-indazol-3-karboxamid |
|||
ADB-D-5Br-INACA |
N-(1-amino-3,3-dimethyl-1-oxobutan-2-yl)-5-brom-1-decyl-1H-indazol-3-karboxamid |
|||
ADB-FUBHQUCA |
N-(1-amino-3,3-dimethyl-1-oxobutan-2-yl)-1-(4-fluorfenyl)methyl-1,4-dihydrochinolin-3-karboxamid |
|||
ADB-FUBIACA |
N-(1-amino-3,3-dimethyl-1-oxobutan-2-yl)-1-(4-fluorbenzyl)-1H-indol-3-acetamid |
|||
ADB-HEXINACA |
N-(1-amino-3,3-dimethyl-1-oxobutan-2-yl)-1-hexyl-1H-indazol-3-karboxamid |
|||
ADB-IACA |
2-[2-(1H-indol-3-yl)acetamido]-3,3-dimethylbutanamid |
|||
ADB-P-5Br-INACA |
N-(1-amino-3,3-dimethyl-1-oxobutan-2-yl)-5-brom-1-pentyl-1H-indazol-3-karboxamid |
|||
ADMB-3TMS-PRINACA |
N-(1-amino-3,3-dimethyl-1-oxobutan-2-yl)-1-(3-(trimethylsilyl)propyl)-1H-indazol-3-karboxamid |
|||
ADMB-INACA |
N-(1-amino-3,3-dimethyl-1-oxobutan-2-yl)-1H-indazol-3-karboxamid |
|||
A-FUBIACA |
N-(1-adamantyl)-2-[1-[(4-fluorfenyl)methyl]indol-3-yl]acetamid |
|||
A-PBITMO |
(adamantan-1-yl)(3-pentyl-2-thioxo-2,3-dihydro-1H-benzo[d]imidazol-1-yl)methanon |
|||
A-PONASA |
N-adamantyl-4-(pentyloxy)naftalen-1-sulfonamid |
|||
BENZYL-4CN-BINACA |
N-benzyl-1-(4-kyanobutyl)-1H-indazol-3-karboxamid |
|||
BZO-4en-POXIZID |
N-[(Z)-(2-oxo-1-pent-4-enyl-indolin-3-yliden)amino]benzamid |
|||
BZO-POXIZID |
N-[(Z)-(2-oxo-1-pentyl-indolin-3-yliden)amino]benzamid |
|||
CUMYL-1Cl-CHSINACA |
1-(1-chlorcyklohexyl)sulfonyl-N-(1-methyl-1-fenyl-ethyl)indazol-3-karboxamid |
|||
CUMYL-3TMS-PRINACA |
N-(2-fenylpropan-2-yl)-1-(3-(trimethylsilyl)propyl)-1H-indazol-3-karboxamid |
|||
Cumyl-BC-HpMeGaClone-221 |
(5-(bicyklo[2.2.1]hept-2-yl)methyl)-2-(2-fenylpropan-2-yl)-2,5-dihydro-1H-pyrido[4,3-b]indol-1-on |
|||
Cumyl-CB-MeGaClone |
5-(cyklobutylmethyl)-2-(1-methyl-1-fenyl-ethyl)pyrido [4,3-x]xxxxx-1-xx |
|||
XXXXX-XXXXXX |
1-(xxxxxxxxxxxxxxxx)-X-(2-xxxxxxxxxxx-2-xx)-1X-xxxxx-3-xxxxxxxxxx |
|||
XXXXX-XXXXXXXX |
1-(xxxxxxxxxxxxxxxx)-X-(2-xxxxxxxxxxx-2-xx)-1X-xxxxxxx-3-xxxxxxxxxx |
|||
XXXXX-XXXXXXXX |
1-(xxxxxxxxxxxxxxxxxx)-X-(2-xxxxxxxxxxx-2-xx)-1X-xxxxxxx-3-xxxxxxxxxx |
|||
XXXXX-XXXXX |
X-(2-xxxxxxxxxxx-2-xx)-1X-xxxxxxx-3-xxxxxxxxxx |
|||
XXXXX-XXXXXX |
1-(xxxxxxx[2.2.1]xxxxxx-2-xxxxxxxx)-X-(2-xxxxxxxxxxx-2-xx)-1X-xxxxx-3-xxxxxxxxxx |
|||
XXXXX-XXXXXXXX |
(1-(xxxxxxx[2.2.1]xxxxxx-2-xx)xxxxxx)-X-(2-xxxxxxxxxxx-2-xx)-1X-xxxxxxx-3-xxxxxxxxxx |
|||
XXXXX-XxXXXXX |
X-(2-xxxxxxxxxxx-2-xx)-1-xxxxx-1X-xxxxxxx-3-xxxxxxxxxx |
|||
XXXX-XXXXXX |
xxxxx 3,3-xxxxxxxx-2-[(1-xxxxxxxxxxxxx-3- karbonyl)amino] xxxxxxxx |
|||
XXXXXX |
1-[(4-xxxxxxxxxx)xxxxxx]-1X-xxxxx-3-xxxxxx |
|||
XX-XXXXXXXXXX |
X-{5-xxxx-1-[(4-xxxxxxxxxx)xxxxxx]-4-xxxxxx-2-xxx-1,2-xxxxxxxxxxxxxx-3-xx}xxxxxxxxxxxxxxxxxxxx |
|||
XX-XXXXXXX |
X-xxxxxxxxxx-2-(1-(4-xxxxxxxxxxx)-1X-xxxxx-3-xx)xxxxxxxx |
|||
XX-XXXX |
X-xxxxxxxxxx-2-(1X-xxxxx-3-xx)xxxxxxxx |
|||
XXX-XXX-19 |
X-[(X)-[1-(xxxxxxxxxxxxxxxx)-2-xxx-xxxxxxx-3-xxxxxx]xxxxx]xxxxxxxx |
|||
XXX-XXXX-XXXXXXXX |
xxxxxxxxxxxxxxxx 2-(1-(xxxxxxxxxxxxxxxx)-1X-xxxxxxx-3-xxxxxxxxxxx)-3,3-xxxxxxxxxxxxxxxx |
|||
XX-XXXXX |
X-xxxxxxxxxx-2-(1-xxxxxx-1X-xxxxx-3-xx)xxxxxxxx |
|||
XXXX-5Xx-XXXXX |
xxxxxx 2-(5-xxxx-1X-xxxxxxx-3-xxxxxxxxxxx)-3,3-xxxxxxxxxxxxxxxx |
|||
XXXX-7Xx-XXXXX |
xxxxxx 2-(7-xxxx-1X-xxxxxxx-3-xxxxxxxxxxx)-3,3-xxxxxxxxxxxxxxxx |
|||
XXXX-XXXXXX |
xxxxxx 2-(1-xxxxx-1X-xxxxxxx-3-xxxxxxxxxxx)-3,3-xxxxxxxxxxxxxxxx |
|||
XXXX-XXXXXXXX |
xxxxxx 2-[1-(xxxxxxxxxxxxxxxx)-1X-xxxxxxx-3-xxxxxx xxxxx]-3,3-xxxxxxxxxxxxxxxx |
|||
XXXX-XXXXX |
xxxxxx 2-(1H-indazol-3-karboxamido)-3,3-dimethylbutanoát |
|||
NMDMSB |
1-naftyl 4-xxxxxx-3-(xxxxxxxxxxxxxxxxx)-xxxxxxx |
|||
XXX-3 |
X-({2-[1-(5-xxxxxxxxxxx)-1X-xxxxx-3-xx]-1,3-xxxxxxx-4-xx}xxxxxx)-2-xxxxxxx-X-xxxxxxxxxxxxxxx |
Xxxxxx xxxxxxxxxxxxx xxxxxxxxxxxxxxx látek, xx na xxxxxxxx xxxxxxx, xxxxxxxxx x xxxxx xxxxxxx ve xxxxx xxxxxxxxx, kdy xxxx xxxxxxxxxxxxx xxxxx xxxxxxxxx podle xxxxxxxxxx xxxxxxxxxx označení x xxxx x xxxxxx xxxxxxxxxxxxxxx xxxxx xxxxxxxxx x xxxxx xxxxxxx xx xxxxx případech, xxx xxxxx xxxxxxxxx.
Informace
Právní xxxxxxx x. 11/2025 Sb. xxxxx xxxxxxxxx xxxx 17.1.2025.
Xx xxx xxxxxxxx xxxxxx xxxxxxx xxxxx xxxxx xx doplňován.
Znění jednotlivých xxxxxxxx norem xxxxxx xxxxxxxx předpisů x xxxxxxxx xxxx aktualizováno, xxxxx se jich xxxxxx derogační změna xxxxx uvedeného právního xxxxxxxx.